Covestor’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10K Buy
483
+8
+2% +$155 0.01% 1588
2026
Q1
$8K Sell
475
-331
-41% -$5.8K 0.01% 1564
2025
Q4
$14K Hold
806
0.01% 1435
2025
Q3
$15K Sell
806
-2
-0.2% -$34 0.01% 1397
2025
Q2
$13K Sell
808
-6
-0.7% -$91 0.01% 1407
2025
Q1
$14K Buy
814
+4
+0.5% +$66 0.01% 1308
2024
Q4
$14K Buy
810
+6
+0.7% +$106 0.01% 1347
2024
Q3
$15K Sell
804
-16
-2% -$284 0.01% 1324
2024
Q2
$14K Hold
820
0.01% 1336
2024
Q1
$12K Buy
820
+379
+86% +$5.72K 0.01% 1446
2023
Q4
$8K Buy
441
+11
+3% +$168 0.01% 1683
2023
Q3
$7K Sell
430
-35
-8% -$621 0.01% 1621
2023
Q2
$9K Sell
465
-24
-5% -$463 0.01% 1506
2023
Q1
$9K Sell
489
-1,934
-80% -$39K 0.01% 1363
2022
Q4
$47K Sell
2,423
-641
-21% -$12.6K 0.04% 755
2022
Q3
$64K Buy
3,064
+2,655
+649% +$67.5K 0.06% 591
2022
Q2
$11K Buy
409
+3
+0.7% +$89 0.01% 1176
2022
Q1
$13K Sell
406
-665
-62% -$20.9K 0.01% 1221
2021
Q4
$36K Buy
+1,071
New +$35.8K 0.05% 700

Other funds holding HR

Covestor's HR Position: Q2 2026 in Review

Covestor increased its Healthcare Realty (HR) stake by 1.7% in Q2 2026, buying an estimated $155 and bringing the position to 483 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1588.

Covestor first reported a position in HR in Q4 2021 and has held it in 19 quarters since. The position peaked at $64K in Q3 2022. 458 funds tracked by Wall St. Rank hold HR as of Q2 2026.

  • Covestor held 483 shares of Healthcare Realty worth $10K as of Q2 2026.
  • Covestor bought 8 Healthcare Realty shares in Q2 2026, an estimated $155.
  • Healthcare Realty made up 0.01% of Covestor's portfolio in Q2 2026, its #1588 holding.
  • Covestor first reported a position in Healthcare Realty in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Healthcare Realty position peaked at $64K in Q3 2022.
  • 458 funds tracked by Wall St. Rank held Healthcare Realty as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.